More generic-drug makers have filed for U.S. approval to market generic versions of Pfizer Inc.'s (PFE) blockbuster cholesterol pill Lipitor. New York-based Pfizer disclosed in a regulatory filing Thursday that Dr.

Read the original article
Brought to you by Yahoo! News

Return to Epilepsy News